C07K 5/0827
Containing heteroatoms different from o, s, or n
Official title: {containing heteroatoms different from O, S, or N}
C07K5/0827 (Containing heteroatoms different from o, s, or n) appears on 375 US grants and 342 published applications in this corpus.
Search patents in C07K- Granted patents
- 375
- Published applications
- 342
- Assignees
- 221
- Inventors
- 1,005
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 7 | 0 |
| 1985 | 6 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 7 | 0 |
| 1990 | 4 | 0 |
| 1991 | 7 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 11 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 16 | 0 |
| 2001 | 6 | 0 |
| 2002 | 6 | 11 |
| 2003 | 7 | 18 |
| 2004 | 7 | 21 |
| 2005 | 8 | 31 |
| 2006 | 17 | 20 |
| 2007 | 12 | 20 |
| 2008 | 19 | 17 |
| 2009 | 15 | 24 |
| 2010 | 13 | 20 |
| 2011 | 16 | 19 |
| 2012 | 26 | 29 |
| 2013 | 17 | 14 |
| 2014 | 13 | 11 |
| 2015 | 9 | 14 |
| 2016 | 14 | 14 |
| 2017 | 10 | 6 |
| 2018 | 4 | 8 |
| 2019 | 4 | 14 |
| 2020 | 5 | 5 |
| 2021 | 7 | 4 |
| 2022 | 3 | 5 |
| 2023 | 2 | 2 |
| 2024 | 1 | 6 |
| 2025 | 2 | 4 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oligopeptide linker intermediate and preparation method thereof10 Mar 2026US 12,570,692 B2Mabplex International Co., Ltd.
- Compound having biological activity such as antiviral activity10 Feb 2026US 12,545,671 B2National Center for Global Health and Medicine
- Peptidomimetics for the treatment of coronavirus and picorna virus infections8 Apr 2025US 12,268,723 B2Emory University
- Cyclic peptide compound simulating natural product structure, and method for preparation thereof7 Jan 2025US 12,187,811 B2Nankai University
- Peptide macrocycles against Acinetobacter baumannii18 Jun 2024US 12,012,466 B2Hoffmann-La Roche Inc.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
- Cell membrane-penetrating peptide for conjugation20 Aug 2026US 2026/0242827 A1AGC Inc.
- Cationic cross-linked vesicles23 Jul 2026US 2026/0207772 A1Bracco Suisse SA
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
- Pharmaceutical compounds for the treatment of complement mediated disorders5 Mar 2026US 2026/0062443 A1Alexion Pharmaceuticals, Inc.
Most cited
By later US patents
- Boronic ester and acid compounds, synthesis and uses183US 6,083,903 ALeukoSite, Inc. · 2000
- Boronic ester and acid compounds175US 5,780,454 AProScript, Inc. · 1998
- .alpha.-Aminoboronic acid peptides142US 4,499,082 AE. I. Du Pont de Nemours and Company · 1985
- Boronic ester and acid compounds, synthesis and uses133US 6,297,217 B1Millennium Pharmaceuticals, Inc. · 2001
- Protease inhibitors114US 4,935,493 AE. I. Du Pont de Nemours and Company · 1990